Literature DB >> 24807765

Adrenal ganglioneuromas: experience from a retrospective study in a Chinese population.

Liping Li1, Jialiang Shao1, Jianjun Gu2, Xiang Wang1, Lianxi Qu3.   

Abstract

PURPOSE: Ganglioneuromas (GNs) are benign neoplasms of combined neural crest, schwannian,and connective tissue origin, occurring rarely in the adrenal glands. The present study is to share our experience regarding diagnostic and therapeutic management of these tumors.
MATERIALS AND METHODS: Adrenal GNs of 15 patients were found incidentally with ultrasonography and were evaluated subsequently with computed tomography (CT) scan. Clinical data as well as follow-up data were collected retrospectively. All the patients received operative resection.
RESULTS: The mean age of the patients was 38.4 years (range, 25-52 years; male to female ratio, 2:1). Of study subjects 11 patients had unilateral GN on the right side, and the remaining 4 on the left side. All but 1 patient were asymptomatic. No hormonal secretion was apparent. Mean size of the tumors in CT scan was 6.27 cm (range, 2.5-14 cm), while 10 were larger than 5 cm. Eight patients underwent open adrenalectomy and the remaining 7 underwent laparoscopic anterior adrenalectomy. Histologically, all 15 neoplasms were completely differentiated,mature GN. We had no mortality or significant morbidity. Mean duration of hospitalization was 5.5 days (range, 3-7 days). There was no recurrence, during a mean followup of 5.4 years (range, 1-10 years).
CONCLUSION: Pre-operative diagnosis of adrenal GNs remains difficult merely according to physical examination. Therefore, we recommend complete operative resection once malignancy cannot be excluded by pre-operative analyses. Laparoscopic adrenalectomy is a reasonable option, at least for tumors ≤ 5 cm.

Entities:  

Mesh:

Year:  2014        PMID: 24807765

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  8 in total

1.  Clinicopathological Features of Ganglioneuroma Originating From the Adrenal Glands.

Authors:  Joon-Hyop Lee; Young Jun Chai; Tae-Hyung Kim; June Young Choi; Kyu Eun Lee; Hyun-Young Kim; Yoo-Seok Yoon; Hyeon Hoe Kim
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

2.  Conus medullaris ganglioneuroma with syringomyelia radiologically mimicking ependymoma: A case report.

Authors:  Kai Wang; Jianping Dai
Journal:  Oncol Lett       Date:  2015-10-19       Impact factor: 2.967

3.  Laparoscopic resection of primary adrenal ganglioneuroma: A case report and review of the literature.

Authors:  Yuan Zhou; Qilian Liang; Wen-Ting Ou; Zhou-Yu Li; Qiu-Long Liu
Journal:  Oncol Lett       Date:  2015-03-09       Impact factor: 2.967

4.  Adrenal Ganglioneuroma: Features and Outcomes of 42 Cases in a Chinese Population.

Authors:  Jing Xie; Jun Dai; Wen-Long Zhou; Fu-Kang Sun
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

5.  Presentation and outcomes of adrenal ganglioneuromas: A cohort study and a systematic review of literature.

Authors:  Kelley N Dages; Jacob D Kohlenberg; William F Young; Mohammad Hassan Murad; Larry Prokop; Michael Rivera; Benzon Dy; Trenton Foster; Melanie Lyden; Travis McKenzie; Geoffrey Thompson; Irina Bancos
Journal:  Clin Endocrinol (Oxf)       Date:  2021-03-22       Impact factor: 3.523

Review 6.  Adrenal ganglioneuroma: What you need to know.

Authors:  Konstantinos S Mylonas; Dimitrios Schizas; Konstantinos P Economopoulos
Journal:  World J Clin Cases       Date:  2017-10-16       Impact factor: 1.337

7.  Computed tomography characteristics of adrenal ganglioneuroma: a retrospective analysis of 30 pathologically-confirmed cases.

Authors:  Meihua Shao; Wenming Zhang; Zhongfeng Niu; Songkuan Chen; Yuzhu Jia; Yongyu An; Fangmei Zhu; Jian Wang
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

8.  Adrenal ganglioneuroma resected for suspicious malignancy: multicenter review of 25 cases and review of the literature.

Authors:  Dorit Esther Zilberman; Tomer Drori; Gadi Shlomai; Haggi Mazeh; Boris Fishman; Shay Golan; Hen Hendel; Monica Laniado; Zohar A Dotan
Journal:  Ann Surg Treat Res       Date:  2021-07-29       Impact factor: 1.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.